FindTrial
Sign In

Study on ONSD and screening of whole blood markers to predict early neurological prognosis of VA-ECMO patients

Study on ONSD and screening of whole blood markers to predict early neurological prognosis of VA-ECMO patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036815
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve function damage

Interventions

Case series:V-A ECOM, TTM

Sponsors

Ruijin Hospital North, Shanghai Jiao Tong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This prospective study included patients who were implanted R-CS or R-CAd and to be used VA-ECOM and received 35-37 target body temperature management.

Exclusion criteria

Exclusion criteria: Trauma patients and patients <18 years old

Design outcomes

Primary

MeasureTime frame
ONSD was measured;—

Countries

China

Contacts

Public ContactRenying Wang

Ruijin Hospital North, Shanghai Jiao Tong University, School of Medicine

sophier9240@163.com+86 18121263249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026